GLP-1 vs Jardiance for Weight Management: Which Is Right for You?

Understanding Your Options for Weight Management

If you're exploring medications for weight management, you've likely come across both GLP-1 receptor agonists and Jardiance. While both medications can lead to weight loss, they work in fundamentally different ways and have distinct purposes.

GLP-1 medications like Semaglutide and Tirzepatide have gained significant attention for their effectiveness in weight management, while Jardiance (empagliflozin) is primarily an SGLT2 inhibitor used for type 2 diabetes and heart health. Understanding the difference between GLP-1 vs Jardiance for weight management can help you and your healthcare provider determine the best approach for your specific needs.

What Are GLP-1 Receptor Agonists?

GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a naturally occurring hormone in your body. This hormone plays a crucial role in regulating blood sugar levels and appetite.

When you take a GLP-1 medication, it works by slowing down how quickly food leaves your stomach, which helps you feel full longer. It also signals to your brain that you're satisfied, reducing hunger and cravings. Additionally, GLP-1s help your pancreas release the right amount of insulin when your blood sugar rises.

Medications in this class include Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro and Zepbound). These have been specifically studied and approved for weight management, with clinical trials showing significant weight loss results.

What Is Jardiance and How Does It Work?

Jardiance belongs to a different class of medications called SGLT2 inhibitors. It was developed primarily to treat type 2 diabetes and reduce the risk of cardiovascular death in adults with type 2 diabetes and heart disease.

Jardiance works by helping your kidneys remove excess sugar from your body through urine. Instead of targeting appetite or digestion like GLP-1s do, it literally causes you to excrete glucose that would otherwise stay in your bloodstream.

While some people do experience modest weight loss on Jardiance, it's not primarily a weight loss medication. The weight reduction typically comes from losing water weight and some calories through the excreted glucose, but it's generally less significant than what's seen with GLP-1 medications.

Comparing Weight Loss Results

When it comes to weight management effectiveness, GLP-1 medications have a clear advantage. Clinical trials have shown impressive results:

GLP-1 receptor agonists like Semaglutide have demonstrated average weight loss of 15-20% of body weight in clinical studies. Tirzepatide has shown even more impressive results, with some participants losing up to 20-25% of their starting weight.

Jardiance, by contrast, typically results in more modest weight loss—usually around 2-3% of body weight on average. This difference makes sense given that Jardiance wasn't designed primarily for weight management.

It's worth noting that individual results vary with any medication, and weight loss depends on multiple factors including diet, exercise, starting weight, and overall health status.

Side Effects and Considerations

Both medication types come with potential side effects that you should discuss with your healthcare provider.

GLP-1 medications commonly cause gastrointestinal side effects, especially when first starting treatment. These may include nausea, vomiting, diarrhea, and constipation. Most people find these effects diminish over time as their body adjusts to the medication.

Jardiance's most common side effects include urinary tract infections and yeast infections, since it increases sugar in the urine. Some people also experience increased urination and dehydration. Rarely, SGLT2 inhibitors have been associated with a serious condition called diabetic ketoacidosis.

Both medications have more serious but rare potential side effects, which is why medical supervision is essential when taking either one.

Which One Is Right for Your Goals?

The choice between GLP-1 medications and Jardiance depends on your specific health situation and primary goals.

If your main objective is significant weight loss, GLP-1 receptor agonists are generally the more effective choice. They're specifically indicated for chronic weight management in addition to their diabetes benefits.

If you have type 2 diabetes with heart disease or kidney disease, Jardiance might be recommended for its cardiovascular and renal protective benefits, with weight loss as a secondary benefit.

Some people may actually benefit from taking both types of medications together, as they work through different mechanisms. Your healthcare provider can help determine if combination therapy makes sense for you.

For more information about weight management options, visit our blog at ozarihealth.com/blog where we cover various topics related to metabolic health and GLP-1 therapy.

Key Takeaways

• GLP-1 medications are significantly more effective for weight loss, with clinical studies showing 15-25% body weight reduction compared to 2-3% with Jardiance
• They work through different mechanisms—GLP-1s reduce appetite and slow digestion, while Jardiance removes excess sugar through urine
• Jardiance is primarily for diabetes and heart health, with weight loss as a secondary benefit, while GLP-1s are approved specifically for weight management
• The best choice depends on your individual health needs, and some people may benefit from both medications under medical supervision

Frequently Asked Questions

Can I take GLP-1 medications and Jardiance together?

Yes, it's possible to take both medications together, and some people do. GLP-1 receptor agonists and Jardiance work through different mechanisms, so they can complement each other. However, this decision should only be made by your healthcare provider based on your specific medical needs, current health status, and potential drug interactions.

Is Jardiance approved for weight loss like GLP-1 medications?

No, Jardiance is not FDA-approved specifically for weight loss or weight management. It's approved for treating type 2 diabetes and reducing cardiovascular risk in certain patients. While weight loss can occur as a side effect, it's not the primary purpose of the medication. In contrast, certain GLP-1 medications like Wegovy and Zepbound are specifically approved for chronic weight management.

How quickly will I see weight loss results with each medication?

With GLP-1 medications, most people begin seeing weight loss within the first few weeks, with significant results typically appearing after 3-6 months of treatment. Jardiance may produce modest weight loss within the first few months, but the changes are generally less dramatic. Remember that sustainable weight loss takes time with any medication, and results vary significantly between individuals based on lifestyle factors and adherence to treatment.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.